Midostaurin for FLT3-mutated Acute Myeloid Leukaemia – Considerations for Optimal Use-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Midostaurin for FLT3-mutated Acute Myeloid Leukaemia – Considerations for Optimal Use

Published:2019 Issue:1 Volume:15 Page:43
ISSN:2045-5275
Container-title:European Oncology & Haematology
language:en
Short-container-title:

Author:

Ossenkoppele Gert J,

Abstract

Funder

This article is published under the Creative Commons Attribution Non-commercial License.

Publisher

Touch Medical Media, Ltd.

Subject

Oncology,Hematology

Reference75 articles.

1. Acute myeloid leukaemia (AML), 2016. Available at: www.cancerresearchuk.org/about-cancer/acute-myeloid-leukaemia-aml (accessed 12 February 2019).

2. Acute myeloid leukaemia, 2018. Available at: www.leukaemia.org.au/disease-information/leukaemias/acute-myeloid-leukaemia (accessed 13 March 2019).

3. Visser O, Trama A, Stiller C, et al. Incidence, survival and prevalence of myeloid malignancies in Europe.Eur J Cancer. 2012;48:3257–66.

4. Cancer Stat Facts: Leukemia - Acute Myeloid Leukemia (AML), 2018. Available at: https://seer.cancer.gov/statfacts/html/amyl.html (accessed 12 February 2019).

5. Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Blood. 2017;129:424–47.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP